AstraZeneca Expands Its Clinical Research Operations In India - ACRI India

1. AstraZeneca Expands Its Clinical Research Operations In India AstraZeneca, the global science-and-research-led biopharmaceutical company, has officially announced the expansion of its clinical research operations in India. This has been confirmed as the company launched a new dedicated unit in Bangalore, which was inaugurated by Richard Homer, Deputy Head of Mission, British Deputy High Commission, Bangalore. AstraZeneca is, at present, among the top 3 initiators of clinical studies among foreign pharmaceutical companies in India in the past 3 years. And, with the new Development Operations center (at Manyata Business Park), AstraZeneca’s position has only bolstered as a leading clinical research initiator. This expansion by AstraZeneca will focus on managing studies in India to support both global clinical drug development and local business with clinical data and evidence. With this aim, the unit is set to support the development of AstraZeneca’s medicines, hosting clinical trial experts focusing on the company’s core therapeutic areas of the cardiovascular system, respiratory system, metabolism, renal system, and oncology. Dr. Melissa Grady, Sr. Regional Director, Development Operations, said, “Over the last 40 years, India has seen AstraZeneca’s commitment to enhance scientific innovation. Because of the excellent skills of Indian clinical research experts and the improvement of regulations and approval timelines, we are pleased to expand our operations and continue to lead clinical research in India. With the opening of this new office, I am delighted to confirm the company’s continued commitment to the country. It is a next step towards supporting further expansion of both – the team and clinical trial activities in the country."

2. Because India has come up with improving regulations and approval timelines, it has attracted many foreign companies and AstraZeneca is one of them. The company has increased its local clinical trial activities in India during the last four years. As a result, the Development Operations team has grown to a good 33 clinical trial experts, handling more than 20 clinical trials across 150 sites in India! As a matter of fact, with two legal entities in India, AstraZeneca employs 4000 experts working across research & development, clinical functions, sales, marketing, manufacturing, and Information Technology. Mr. Gagandeep Singh Bedi, Managing Director, AstraZeneca Pharma India Limited, in regards to the new Development Operations center, said, “The new Development Operations site will see clinical trial experts working side by side to advance science in our core therapeutic areas – Oncology, Cardiovascular, Renal, Metabolism, and Respiratory. This will support and strengthen our focus on combining the expertise across our business to develop new ways to treat patients and tackle the significant unmet medical needs that exist in areas of non-communicable diseases.” With this initiative from AstraZeneca, India is all set to develop local skills, drive domestic scientific innovation, and promote quality manufacturing, with an aim to improve the overall health outcome in the country. Join the league and get-set-go to get professional top clinical research training in Bangalore from a reputed institute like Avigna Clinical Research Institute. Take the right decision now, and see how your future will boom in the coming years!